Decaffeinated green tea extract rich in epigallocatechin-3-gallate improves insulin resistance and metabolic profiles in normolipidic diet-but not high-fat diet-fed mice

Journal of Nutritional Biochemistry

Volumn 26, Issue 9, 2015, Pages 893-902

  Santana, Aline ^a   Santamarina, Aline ^a   Souza, Gabriel ^b   Mennitti, Laís ^a   Okuda, Marcos ^a   Venancio, Daniel ^a   Seelaender, Marilia ^c   Oller do Nascimento, Claudia ^a   Ribeiro, Eliane ^a   Lira, Fabio ^d   Oyama, Lila ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO JUDAS TADEU UNIVERSITY   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Adipose tissue; Epigalocatechin 3 gallate; Lipid metabolism; Lipolysis; Obesity

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADIPONECTIN; CYTOKINE; EPIGALLOCATECHIN GALLATE; FAT; GREEN TEA EXTRACT; HORMONE SENSITIVE LIPASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LIPID; PLACEBO; TRIACYLGLYCEROL; ANTILIPEMIC AGENT; ANTIOBESITY AGENT; BIOLOGICAL MARKER; CATECHIN; PLANT EXTRACT;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIET SUPPLEMENTATION; EPIDIDYMIS FAT; HISTOPATHOLOGY; INSULIN RESISTANCE; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID DIET; LIPOLYSIS; MALE; METABOLIC PARAMETERS; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RETROPERITONEAL FAT; SERUM; TEA; TRIACYLGLYCEROL BLOOD LEVEL; ABSORPTION; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANALYSIS; ANIMAL; BLOOD; BRAZIL; CAMELLIA SINENSIS; CHEMISTRY; DIETARY SUPPLEMENT; FOOD HANDLING; HYPERLIPIDEMIAS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; OBESITY; PATHOLOGY; PLANT LEAF; RANDOMIZATION; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

MUS;

ABSORPTION, PHYSICOCHEMICAL; ADIPOSE TISSUE, WHITE; ADIPOSITY; ANIMALS; ANTI-OBESITY AGENTS; BIOMARKERS; BRAZIL; CAMELLIA SINENSIS; CATECHIN; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; FOOD HANDLING; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; INSULIN RESISTANCE; MALE; MICE; OBESITY; PLANT EXTRACTS; PLANT LEAVES; RANDOM ALLOCATION; WEIGHT GAIN;

EID: 84938836650     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.03.001     Document Type: Article

References (88)

1. Siriwardhana N., Kalupahana N.S., Cekanova M., Le Mieux M., Greer B., Moustaid-Moussa N. Modulation of adipose tissue inflammation by bioactive food compounds. J Nutr Biochem 2013, 24(4):613-623.
2. Kalupahana N.S., Moustaid-Moussa N., Claycombe K.J. Immunity as a link between obesity and insulin resistance. Mol Aspects Med 2012, 33(1):26-34.
3. Li Z.Y., Wang P., Miao C.Y. Adipokines in inflammation, insulin resistance and cardiovascular disease. Clin Exp Pharmacol Physiol 2011, 38(12):888-896.
4. Greenberg A.S., Obin M.S. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006, 83(2):461S-465S.
5. Steinberg G.R., Kemp B.E., Watt M.J. Adipocyte triglyceride lipase expression in human obesity. Am J Physiol Endocrinol Metab 2007, 293(4):E958-E964.
6. Zimmermann R., Strauss J.G., Haemmerle G., Schoiswohl G., Birner-Gruenberger R., Riederer M., et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004, 306(5700):1383-1386.
7. Tateya S., Kim F., Tamori Y. Recent advances in obesity-induced inflammation and insulin resistance. Front Endocrinol (Lausanne) 2013, 8(4):93.
8. Cao H., Endocrinol J. Adipocytokines in obesity and metabolic disease. J Endocrinol 2014, 220(2):T47-T59.
9. Kao Y.H., Chang H.H., Lee M.J., Chen C.L. Tea, obesity, and diabetes. Mol Nutr Food Res 2006, 50(2):188-210.
10. Cunha C.A., Lira F.S., Rosa Neto J.C., Pimentel G.D., Souza G.I., da Silva C.M., et al. Green tea extract supplementation induces the lipolytic pathway, attenuates obesity, and reduces low-grade inflammation in mice fed a high-fat diet. Mediators Inflamm 2013, 2013:1-8.
11. Moreno M.F., De Laquila R., Okuda M.H., Lira F.S., de Souza G.I., de Souza C.T., et al. 618 Metabolic profile response to administration of pigallocatechin-3-gallate in high-fat-fed mice. Diabetol Metab Syndr 2014, 6(1):84.
12. Okuda M.H., Zemdegs J.C., de Santana A.A., Santamarina A.B., Moreno M.F., Hachul A.C., et al. Green tea extract improves high fat diet-induced hypothalamic inflammation, without affecting the serotoninergic system. J Nutr Biochem 2014, 25(10):1084-1089.
13. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123(11):1939-1951.
14. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18(6):499-502.
15. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419.
16. Folch J., Lees M., Sloane Stanley G.H. A simplemethod for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226(1):497-509.
17. Hidalgo J.V., Bronsert P., Orlowska-Volk M., Díaz L.B., Stickeler E., Werner M., et al. Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas. Front Immunol 2014, 5:632.
18. Hodges R.E., Krehl W.A. The role of carbohydrates in lipid metabolism. Am J Clin Nutr 1965, 17(5):334-346. [Review].
19. Truswell A.S. Food carbohydrates and plasma lipids-an update. Am J Clin Nutr 1994, 59(3 Suppl.):710S-718S. [Review].
20. Frayn K.N., Kingman S.M. Dietary sugars and lipid metabolism in humans 1995, 62(1 Suppl.):250S-261S. [discussion 261S-263S, Review].
21. Parks E.J., Hellerstein M.K. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr 2000, 71(2):412-433. [Review].
22. Brussaard J.H., Katan M.B., Groot P.H., Havekes L.M., Hautvast J.G. Serum lipoproteins of healthy persons fed a low-fat diet or a polyunsaturated fat diet for three months. A comparison of two cholesterol-lowering diets. Atherosclerosis 1982, 42(2-3):205-219.
23. West C.E., Sullivan D.R., Katan M.B., Halferkamps I.L., van der Torre H.W. Boys from populations with high-carbohydrate intake have higher fasting triglyceride levels than boys from populations with high-fat intake. Am J Epidemiol 1990, 131(2):271-282.
24. Karpe F. Postprandial lipid metabolism in relation to coronary heart disease. Proc Nutr Soc 1997, 56(2):671-678. [Review].
25. Chen W.P., Ho B.Y., Lee C.L., Lee C.H., Pan T.M. Red mold rice prevents the development of obesity, dyslipidemia and hyperinsulinemia induced by high-fat diet. Int J Obes 2008, 32:1694-1704.
26. Akagiri S., Naito Y., Ichikawa H., Mizushima K., Takagi T., Handa O. A mouse model of metabolic syndrome; increase in visceral adipose tissue precedes the development of fatty liver and insulin resistance in high-fat diet-fed male KK/Tamice. J Clin Biochem Nutr 2008, 42:150-157.
27. Buettner R., Scholmerich J., Bollheimer L.C. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity 2007, 15:798-808.
28. Picchi M.G., Mattos A.M., Barbosa M.R., Duarte C.P., Gandini Mde A., Portari G.V., et al. A high-fat diet as amodel of fatty liver disease in rats. Acta Cir Bras 2011, 26(Suppl. 2):25-30.
29. Schrauwen P., Westerterp K.R. The role of high-fat diets and physical activity in the regulation of body Weight. Br J Nutr 2000, 84:417-427.
30. Willett W.C. Is dietary fat a major determinant of body fat?. Am J Clin Nutr 1998, 67:556-562.
31. Hoefel A.L., Hansen F., Rosa P.D., Assis A.M., Silveira S.L., Denardin C.C., et al. The effects of hypercaloric diets on glucose homeostasis in the rat: influence of saturated and monounsaturated dietary lipids. Cell Biochem Funct 2011, 29(7):569-576.
32. Shab-Bidar S., Hosseini-Esfahani F., Mirmiran P., Hosseinpour-Niazi S., Azizi F. Metabolic syndrome profiles, obesity measures and intake of dietary fatty acids in adults: Tehran Lipid and Glucose Study. J Hum Nutr Diet 2014, 27(Suppl. 2):1-11.
33. Bruder-Nascimento T., Campos D.H., Alves C., Thomaz S., Cicogna A.C., Cordellini S. Effects of chronic stress and high-fat diet onmetabolic and nutritional parameters in Wistar rats. Arq Bras Endocrinol Metabol 2013, 57(8):642-649.
34. El Akoum S., Lamontagne V., Cloutier I., Tanguay J.F. Nature of fatty acids in high fat diets differentially delineates obesity-linked metabolic syndrome components in male and female C57BL/6 J mice. Diabetol Metab Syndr 2011, 14(3):34.
35. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259(5091):87-91.
36. Medrikova D., Jilkova Z.M., Bardova K., Janovska P., Rossmeisl M., Kopecky J. Sex differences during the course of diet-induced obesity in mice: adipose tissue expandability and glycemic control. Int J Obes (Lond) 2012, 36(2):262-272.
37. Wu D., Ren Z., Pae M., Han S.N., Meydani S.N. Diet-induced obesity has a differential effect on adipose tissue and macrophage inflammatory responses of young and old mice. Biofactors 2013, 39(3):326-333.
38. Korou L.M., Doulamis I.P., Tzanetakou I.P., Mikhailidis D.P., Perrea D.N. The effect of biological age on the metabolic responsiveness of mice fed a high-fat diet. Lab Anim 2013, 47(4):241-244.
39. Lee Y.S., Li P., Huh J.Y., Hwang I.J., Lu M., Kim J.I., et al. Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes 2011, 60(10):2474-2483.
40. Buettner R., Parhofer K.G., Woenckhaus M., Wrede C.E., Kunz-Schughart L.A., Schölmerich J., et al. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol 2006, 36(3):485-501.
41. Metabolic profile response to administration of epigallocatechin-3-gallate in high-fat-fed mice. Diabetol Metab Syndr 2014, 6(1):84.
42. Dias F.M., Leffa D.D., Daumann F., Marques Sde O., Luciano T.F., Possato J.C., et al. Acerola (Malpighia emarginata DC.) juice intake protects against alterations to proteins involved in inflammatory and lipolysis pathways in the adipose tissue of obese mice fed a cafeteria diet. Lipids Health Dis 2014, 4:1-9.
43. dos Santos B., Estadella D., Hachul A.C., Okuda M.H., Moreno M.F., Oyama L.M., et al. Effects of a diet enriched with polyunsaturated, saturated, or trans fatty acids on cytokine content in the liver, white adipose tissue, and skeletal muscle of adult mice. Mediators Inflamm 2013, 2013:1.10.
44. Aihara K., Osaka M., Yoshida M. Oral administration of the milk casein-derived tripeptide Val-Pro-Pro attenuates high-fat diet-induced adipose tissue inflammation in mice. Br J Nutr 2014, 112(4):513-519.
45. Ahmadian M., Wang Y., Sul H.S. Lipolysis in adipocytes. Int J Biochem Cell Biol 2010, 42(5):555-559.
46. Arner P., Langin D. Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance. Trends Endocrinol Metab 2014, 25(5):255-262.
47. Ray H., Pinteur C., Frering V., Beylot M., Large V. Depot-specific differences in perilipin and hormone-sensitive lipase expression in lean and obese. Lipids Health Dis 2009, 18(8):58.
48. De Naeyer H., Ouwens D.M., Van Nieuwenhove Y., Pattyn P., 'tHart L.M., Kaufman J.M., et al. Combined gene and protein expression of hormone-sensitive lipase and adipose triglyceride lipase, mitochondrial content, and adipocyte size in subcutaneous and visceral adipose tissue of morbidly obese men. Obes Facts 2011, 4(5):407-416.
49. Tinahones F.J., Garrido-Sanchez L., Miranda M., García-Almeida J.M., Macias-Gonzalez M., Ceperuelo V., et al. Obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects. Obes Surg 2010, 20(11):1559-1567.
50. Lee M.J., Maliakal P., Chen L., Meng X., Bondoc F.Y., Prabhu S., et al. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 2002, 11(10 Pt 1):1025-1032.
51. Oritani Y., Setoguchi Y., Ito R., Maruki-Uchida H., Ichiyanagi T., Ito T. Comparison of (-)-epigallocatechin-3-O-gallate (EGCG) and O-methyl EGCG bioavailability in rats. Biol Pharm Bull 2013, 36(10):1577-1582.
52. Yang C.S., Chen L., Lee M.J., Balentine D., Kuo M.C., Schantz S.P. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 1998, 7(4):351-354.
53. Mereles D., Hunstein W. Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?. Int J Mol Sci 2011, 12(9):5592-5603.
54. Brown A.L., Lane J., Holyoak C., Nicol B., Mayes A.E., Dadd T. Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial. Br J Nutr 2011, 106(12):1880-1889.
55. Hsu C.H., Liao Y.L., Lin S.C., Tsai T.H., Huang C.J., Chou P. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double- blind, and placebo-controlled clinical trial. Altern Med Rev 2011, 16(2):157-163.
56. Basu A., Sanchez K., Leyva M.J., Wu M., Betts N.M., Aston C.E., et al. Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr 2010, 29(1):31-40.
57. Nagao T., Hase T., Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring) 2007, 15(6):1473-1483.
58. Janle E.M., Portocarrero C., Zhu Y., Zhou Q. Effect of long-term oral administration of green tea extract on weight gain and glucose tolerance in Zucker diabetic (ZDF) rats. J Herb Pharmacother 2005, 5(3):55-65.
59. Lee M.S., Kim C.T., Kim I.H., Kim Y. Inhibitory effects of green tea catechin on the lipid accumulation in 3 T3-L1 adipocytes. Phytother Res 2009, 23(8):1088-1091.
60. Chaves V.E., Frasson D., Kawashita N.H. Several agents and pathways regulate lipolysis in adipocytes. Biochimie 2011, 93(10):1631-1640.
61. Ryden M., Dicker A., van Harmelen V., Hauner H., Brunnberg M., Perbeck L., et al. Mapping of early signaling events in tumor necrosis factor-alpha -mediated lipolysis in human fat cells. J Biol Chem 2002, 277(2):1085-1091.
62. Sethi J.K., Hotamisligil G.S. The role of TNF alpha in adipocyte metabolism. Semin Cell Dev Biol 1999, 10(1):19-29.
63. Gasic S., Tian B., Green A. Tumor necrosis factor alpha stimulates lipolysis in adipocytes by decreasing Gi protein concentrations. J Biol Chem 1999, 274(10):6770-6775.
64. Souza S.C., de Vargas L.M., Yamamoto M.T., Lien P., Franciosa M.D., Moss L.G., et al. Overexpression of perilipin A and B blocks the ability of tumor necrosis factor alpha to increase lipolysis in 3 T3-L1 adipocytes. J Biol Chem 1998, 273(38):24665-24669.
65. Souza S.C., Palmer H.J., Kang Y.H., Yamamoto M.T., Muliro K.V., Paulson K.E., et al. TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3 T3-L1 adipocytes. J Cell Biochem 2003, 89(6):1077-1086.
66. Lee B., Shao J. Adiponectin and energy homeostasis. Rev Endocr Metab Disord 2014, 15(2):149-156.
67. Kahn B.B., Alquier T., Carling D., Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005, 1:15-25.
68. Lavoie F., Frisch F., Brassard P., Normand-Lauzière F., Cyr D., Gagnon R., et al. Relationship between total and high molecular weight adiponectin levels and plasma nonesterified fatty acid tolerance during enhanced intravascular triacylglycerol lipolysis in men. J Clin Endocrinol Metab 2009, 94(3):998-1004.
69. Bullo M., Salas-Salvado J., Garcia-Lorda P. Adiponectin expression and adipose tissue lipolytic activity in lean and obese women. Obes Surg 2005, 15:382-386.
70. Mallat Z., Heymes C., Ohan J., Faggin E., Lesèche G., Tedgui A. Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol 1999, 19:611-616.
71. Jung S.H., Park H.S., Kim K.S., Choi W.H., Ahn C.W., Kim B.T., et al. Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss. J Nutr Biochem 2008, 19(6):371-375.
72. Manigrasso M.R., Ferroni P., Santilli F., et al. Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. J Clin Endocrinol Metab 2005, 90:5876-5879.
73. Ugochukwu N.H., Figgers C.L. Caloric restriction inhibits up-regulation of inflammatory cytokines and TNF-α, and activates IL-10 and haptoglobin in the plasma of streptozotocin-induced diabetic rats. J Nutr Biochem 2007, 18:120-126.
74. Formoso G., Taraborrelli M., Guagnano M.T., D'Adamo M., Di Pietro N., Tartaro A., et al. Magnetic resonance imaging determined visceral fat reduction associates with enhanced IL-10 plasma levels in calorie restricted obese subjects. PLoS One 2012, 7(12):e5277.
75. Maron D.J., Lu G.P., Cai N.S., Wu Z.G., Li Y.H., Chen H., et al. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med 2003, 163(12):1448-1453.
76. Batista Gde A., Cunha C.L., Scartezini M., von der Heyde R., Bitencourt M.G., Melo F. Prospective double-blind crossover study of Camellia sinensis (green tea) in dyslipidemias. Arq Bras Cardiol 2009, 93(2):128-134.
77. Stoeckman A.K., Towle H.C. The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression. J Biol Chem 2002, 277(30):27029-27035.
78. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257(1):79-83.
79. Ryan A.S., Berman D.M., Nicklas B.J., Sinha M., Gingerich R.L., Meneilly G.S., et al. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 2003, 26(8):2383-2388.
80. Li S., Shin H.J., Ding E.L., van Dam R.M. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009, 302(2):179-188.
81. Trujillo M.E., Scherer P.E. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005, 257(2):167-175. [Review].
82. Serisier S., Leray V., Poudroux W., Magot T., Ouguerram K., Nguyen P. Effects of greentea on insulin sensitivity, lipid profile and expression of PPARalpha and PPARgamma and their target genes in obese dogs. Br J Nutr 2008, 99(6):1208-1216.
83. Igarashi K., Honma K., Yoshinari O., Nanjo F., Hara Y. Effects of dietarycatechins on glucose tolerance, blood pressure and oxidative status in Goto-Kakizaki rats. J Nutr Sci Vitaminol (Tokyo) 2007, 53(6):496-500.
84. Fukino Y., Ikeda A., Maruyama K., Aoki N., Okubo T., Iso H. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr 2008, 62(8):953-960.
85. Josic J., Olsson A.T., Wickeberg J., Lindstedt S., Hlebowicz J. Does green tea affect postprandial glucose, insulin and satiety in healthy subjects: a randomized controlled trial. Nutr J 2010, 9:63.
86. Polychronopoulos E., Zeimbekis A., Kastorini C.M., Papairakleous N., Vlachou I., Bountziouka V., et al. Effects of black and green tea consumption on blood glucose levels in non-obese elderly men and women from Mediterranean Islands (MEDIS epidemiological study). Eur J Nutr 2008, 47(1):10-16.
87. Zheng X.X., Xu Y.L., Li S.H., Hui R., Wu Y.J., Huang X.H. Effects of green tea catechins with or without caffeine on glycemic control in adults: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2013, 97(4):750-762.
88. Bajerska J., Wozniewicz M., Jeszka J., Drzymala-Czyz S., Walkowiak J. Green tea aqueous extract reduces visceral fat and decreases protein availability in rats fed with a high-fat diet. Nutr Res 2011, 31(2):157-164.